Cargando…
Mutations of p53 associated with pancreatic cancer and therapeutic implications
Pancreatic adenocarcinoma is a malignancy with rising incidence and grim prognosis. Despite improvements in therapeutics for treating metastatic pancreatic cancer, this disease is invariably fatal with survival time less than a few years. New molecular understanding of the pathogenesis of pancreatic...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Hepato-Biliary-Pancreatic Surgery
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382872/ https://www.ncbi.nlm.nih.gov/pubmed/34402431 http://dx.doi.org/10.14701/ahbps.2021.25.3.315 |